Researchers discover gene that permanently stops cancer cell proliferation

ScienceRocks

Democrat all the way!
Mar 16, 2010
59,455
6,792
1,900
The Good insane United states of America
Researchers discover gene that permanently stops cancer cell proliferation
August 1, 2012
Researchers at Case Western Reserve University School of Medicine have discovered a mutant form of the gene, Chk1, that when expressed in cancer cells, permanently stopped their proliferation and caused cell death without the addition of any chemotherapeutic drugs. This study illustrates an unprecedented finding, that artificially activating Chk1 alone is sufficient to kill cancer cells.

"We have identified a new direction for cancer therapy and the new direction is leading us to a reduction in toxicity in cancer therapy, compared with chemotherapy or radiation therapy," said Dr. Zhang, assistant professor, Department of Pharmacology at the School of Medicine, and member of the university's Case Comprehensive Cancer Center. "With this discovery, scientists could stop the proliferation of cancer cells, allowing physicians time to fix cells and genetic errors." While studying the basic mechanisms for genome integrity, Dr. Zhang's team unexpectedly discovered an active mutant form of human Chk1, which is also a non-natural form of this gene. This mutation changed the protein conformation of Chk1 from the inactive form into an active form. Remarkably, the research team discovered that when expressed in cancer cells, this active mutant form of Chk1 permanently stopped cancer cell proliferation and caused cell death in petri dishes even without the addition of any chemotherapeutic drugs. The biggest advantage of this potential strategy is that no toxic chemotherapeutic drug is needed to achieve the same cancer killing effect used with a combination of Chk1 inhibitors and chemotherapeutic drugs. Cells respond to DNA damage by activating networks of signaling pathways, termed cell cycle checkpoints. Central to these genome pathways is the protein kinase, called Chk1. Chk1 facilitates cell survival, including cancer cells, under stressful conditions, such as those induced by chemotherapeutic agents, by placing a temporary stop on the cell cycle progression and coordinating repair programs to fix the DNA errors.

Read more at: Researchers discover gene that permanently stops cancer cell proliferation
 
Last edited:
Chemotherapy counter-productive...
:eusa_eh:
Chemo 'undermines itself' through rogue response
5 August 2012 - Chemotherapy can undermine itself by causing a rogue response in healthy cells, which could explain why people become resistant, a study suggests.
The treatment loses effectiveness for a significant number of patients with secondary cancers. Writing in Nature Medicine, US experts said chemo causes wound-healing cells around tumours to make a protein that helps the cancer resist treatment. A UK expert said the next step would be to find a way to block this effect. Around 90% of patients with solid cancers, such as breast, prostate, lung and colon, that spread - metastatic disease - develop resistance to chemotherapy. Treatment is usually given at intervals, so that the body is not overwhelmed by its toxicity. But that allows time for tumour cells to recover and develop resistance.

In this study, by researchers at the Fred Hutchinson Cancer Research Center in Seattle looked at fibroblast cells, which normally play a critical role in wound healing and the production of collagen, the main component of connective tissue such as tendons. But chemotherapy causes DNA damage that causes the fibroblasts to produce up to 30 times more of a protein called WNT16B than they should. The protein fuels cancer cells to grow and invade surrounding tissue - and to resist chemotherapy.

Success v failure

It was already known that the protein was involved in the development of cancers - but not in treatment resistance. The researchers hope their findings will help find a way to stop this response, and improve the effectiveness of therapy. Peter Nelson, who led the research, said: "Cancer therapies are increasingly evolving to be very specific, targeting key molecular engines that drive the cancer rather than more generic vulnerabilities, such as damaging DNA. "Our findings indicate that the tumour microenvironment also can influence the success or failure of these more precise therapies."

Prof Fran Balkwill, a Cancer Research UK expert on the microenvironment around tumours, said: "This work fits with other research showing that cancer treatments don't just affect cancer cells, but can also target cells in and around tumours. "Sometimes this can be good - for instance, chemotherapy can stimulate surrounding healthy immune cells to attack tumours. "But this work confirms that healthy cells surrounding the tumour can also help the tumour to become resistant to treatment. "The next step is to find ways to target these resistance mechanisms to help make chemotherapy more effective."

BBC News - Chemo 'undermines itself' through rogue response
 

New Topics

Forum List

Back
Top